RTWG — RTW Biotech Opportunities Cashflow Statement
0.000.00%
Last trade - 00:00
- £403.15m
- £401.93m
- $4.17m
- 21
- 46
- 64
- 36
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 38.7 | 161 | -64.3 | -39.4 | 83.2 |
Non-Cash Items | -40 | -170 | 54.3 | 31.3 | -94.1 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -64.9 | -47.3 | -34.8 | 18.5 | 44.5 |
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -66.2 | -56.8 | -44.9 | 10.4 | 33.5 |
Financing Cash Flow Items | 95 | -4.15 | -4.97 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 110 | 37.6 | 39.1 | 0 | -2.09 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 43.8 | -19.2 | -5.78 | 10.4 | 31.4 |